<DOC>
	<DOCNO>NCT03047772</DOCNO>
	<brief_summary>The benefit current stem cell transplantation therapy myocardial infarction limit low survival rate stem cell . The purpose study test whether intensive Atorvastatin therapy improve outcome patient impaired leave ventricle function acute myocardial infarction underwent intracoronary transfer autologous bone marrow mesenchymal stem cell .</brief_summary>
	<brief_title>Transplantation Efficacy Autologous Bone Marrow Mesenchymal Stem Cells With Intensive Atorvastatin AMI Patients</brief_title>
	<detailed_description>The major challenge successful stem cell therapy myocardial infarction low survival rate implant cell damage tissue . Atorvastatin , HMG-CoA reductase inhibitor , multiple biological activity independent cholesterol-lowering action.This study perform find information strategy Atorvastatin therapy improve survival implant cell , autologous bone marrow mesenchymal stem cell transplantation . Patients 30 75 year age receive autologous bone marrow mesenchymal stem cell transplant may eligible study . These patient receive autologous bone marrow mesenchymal stem cell transplantation intracoronary undergo Percutaneous Coronary Intervention regular high dose Atorvastatin treatment . The objective evaluation perform baseline 12 month follow-up . Heart function test may include follow : Electrocardiogram ( EKG ) evaluate electrical activity heart . Electrodes place chest transmit information heart machine . Echocardiogram ( Echo ) ultrasound test use sound wave create image heart examine function heart chamber valve . Gated acquisition scan nuclear medicine test use small amount radioactive chemical inject vein . A special scanner creates image heart examine beat motion muscle . MRI evaluate function heart chamber beat motion muscle .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Patients first time STelevation myocardial infarction ( STEMI ) . 2 . Patients undergo PCI 2 5 day . 3 . Patients without PCI emergency coronary angiography show criminal coronary artery recanalized . 4 . Left ventricular infarction area seriously hypokinesis movement 5 . Left ventricular ejection fraction &lt; =45 % base coronary angiography echocardiography . Any one follow exclusion criterion sufficient disqualify patient study . 1 . Patients without emergency PCI criminal coronary artery fail recanalized . 2 . Patients nonSTelevation myocardial infarction . 3 . Patients normal leave ventricular function . 4 . Patients mechanical complication myocardial infarction . 5 . Patients malignant tumor . 6 . Patients infection disease . 7 . Less 6 month since last episode stroke . 8 . Patients hematological disease ( leukemia , myeloproliferative disease , myelodysplastic syndrome ) . 9 . ALT ( GPT ) exceed 100 IU/L . 10 . Leukocytes less 4,000/µL exceed 10,000/µL . 11 . Platelets le 100,000/µL . 12 . Hemoglobin le 10 g/dL . 13 . Pregnant nursing patient , may pregnant , plan become pregnant end study period . 14 . Any reason Clinical Supervisors Clinical Researchers may consider case unsuitable study .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>